Form 4: Disc Medicine CEO John Quisel Acquires Shares and Options in Company
SEC Form 4 Filing
Disc Medicine's CEO, John Quisel, acquired shares and stock options in the company on January 10, 2024, according to a Form 4 filing.
Summary
- On January 10, 2024, John Quisel, the CEO of Disc Medicine, Inc., acquired 66,365 shares of common stock at $0.00 per share.
- Following this transaction, Quisel directly owns 69,065 shares of Disc Medicine.
- Quisel also acquired options to purchase 99,550 shares of common stock at an exercise price of $63.90.
- These options vest 25% on January 10, 2025, and the remainder vest in 36 equal monthly installments thereafter, contingent upon continued service.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the CEO's purchase of shares and options signals confidence, but it's a routine transaction.
Positives
- The CEO's acquisition of shares and options could be interpreted as a sign of confidence in the company's future prospects.
Future Outlook
The vesting schedule of the options suggests a long-term commitment from the CEO, as continued service is required for full vesting.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's value and future performance. This Form 4 filing is a routine disclosure required by the SEC.
Stakeholder Impact
- Shareholders may view the CEO's increased stake as a positive signal.
- Employees may see it as a sign of leadership's commitment to the company's success.
Key Dates
| Date | Description |
|---|---|
| 01/10/2024 | Date of transaction: CEO acquired shares and stock options. |
| 01/10/2025 | 25% of the stock options vest. |
| 01/09/2034 | Expiration date of the stock options. |
| 03/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.